| Literature DB >> 19748727 |
Lorenzo Magrassi1, Nicola Marziliano, Frediano Inzani, Pamela Cassini, Ilaria Chiaranda, Miran Skrap, Stefano Pizzolito, Cesare Arienta, Eloisa Arbustini.
Abstract
By qPCR we found that EDG3 and SHC3 were amplified in 60% of ependymomas but none in choroid plexus papillomas. In ependymomas EDG3 and SHC3 amplification increased Shc3 protein levels while EDG3 was less affected. Both proteins were co-immunoprecipitated from ependymoma and Shc3 was tyrosine phosphorylated thus presumably active. We showed by digestion with N-glycosidase-F that EDG3 was glycosylated indicating that EDG3 protein was not retained in the endoplasmic reticulum. The co-immunoprecipitation of Shc3 and EDG3 proteins from ependymomas with amplification of SHC3 and EDG3 genes suggests that the two proteins co-operate and are important for ependymomas in vivo. 2009 Elsevier Ireland Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19748727 DOI: 10.1016/j.canlet.2009.08.023
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679